Role for transforming growth factor-[BETA]1 in inhibiting endothelial cell proliferation in experimental alcoholic liver disease

American Journal of Pathology

Volumn 148, Issue 3, 1996, Pages 739-747

  Nanji, Amin A ^a   Tahan, Steven R ^a   Golding, Matthew ^b   Khwaja, Shamsuddin ^a   Rahemtulla, Amir ^a   Lalani, El Nasir ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; VIMENTIN;

ALCOHOL LIVER DISEASE; ANIMAL; ARTICLE; CELL DIVISION; IMMUNOHISTOCHEMISTRY; LIVER; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; VASCULAR ENDOTHELIUM; WISTAR RAT;

ANIMALS; CELL DIVISION; ENDOTHELIUM, VASCULAR; IMMUNOHISTOCHEMISTRY; LIVER; LIVER DISEASES, ALCOHOLIC; MALE; RATS; RATS, WISTAR; TRANSFORMING GROWTH FACTOR BETA; VIMENTIN;

EID: 0030092075     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Schaffner F, Popper H Capillarization of hepatic sinusoids in man. Gastroenterotogy 1963, 44:239-242
2. Witte MH, Borgs P, Way DL, Ramirez G. Bernes MJ, Witte CL Alcohol, hepatic sinusoidal microcirculation and chronic liver disease Alcohol 1992, 9 473-478
3. Nanji AA, French SW Dietary factors and alcoholic cirrhosis. Alcohol Clin Exp Res 1986, 10.271-273
4. Nanji AA, Mendenhall CL, French SW: Beef fat prevents alcoholic liver disease in the rat. Alcohol Clin Exp Res 1989, 13:15-19
5. Nanji AA, French SW Dietary linoleic acid is required for development of experimental alcoholic liver disease Life Sci 1989, 44:223-227
6. Nanji AA, Tahan SR, Wei Y, Sadrzadeh SMH: Endothelial cell proliferation is a determinant of pathologic changes in experimental alcoholic liver disease Hepatology 1993, 18:273A
7. 1/S arrest correlates with severity of alcoholic liver injury in the rat. Gastroenterology 1994, 107:818-823
8. Waseem NH, Lane DP. Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA) structural conservation and detection of a nucleolar form J Cell Sci 1990, 96:121-129
9. Celis JA, Celis A: Cell cycle dependent variations in distribution of the nuclear protein cyclin/proliferating cell nuclear antigen in cultured cells Proc Natl Acad Sci USA 1985, 82:3262-3266
10. Koff A, Ohtsuki M, Polyak K, Roberts JM, Massague J: Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinases by TGF-β. Science 1993, 260:536-539
11. 1/S transition of mammalian cells. J Cell Biochem 1994, 54. 379-386
12. Czaja MJ, Weiner FR, Flanders KC, Giambrone MA, Wind R, Biempic A, Zern MA In vitro and in vivo association of transforming growth factor-β1 with hepatic fibrosis J Cell Biol 1989, 108.2477-2482
13. Nakatsukasa H, Nagy P, Evarts RP, Hsia LC, Marsden E, Thorgeirsson SS Cellular distribution of transforming growth factor-β1 and procollagen types I, III and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest 1990, 85.1833-1843
14. Castilla A, Prieto J, Fausto N. Transforming growth factor-β1 and -α in chronic liver disease effects of interferon-α therapy N Engl J Med 1991, 324:933-940
15. Muller G, Behrens J, Nussbaumer U, Bohlein P, Birchmeir W Inhibitory action of transforming growth factor-β on endothelial cells. Proc Natl Acad Sci USA 1987, 84:5600-5604
16. Heinmark RL, Twardzik DT, Schwartz SM: Inhibition of endothelial regeneration by type-β transforming growth factor from platelets Science 1986, 233 1078-1080
17. 1 cell cycle arrest. J Cell Physiol 1993, 156:48-55
18. Tsukamoto H, Gaal K, French SW Insights into the pathogenesis of alcoholic liver necrosis and fibrosis Hepatology 1990. 12 599-608
19. French SW, Miyamoto K Tsukamoto H Ethanol-induced hepatic fibrosis in the rat. Alcohol Clin Exp Res 1986, 13S-19S
20. Nanji AA, Khwaja S, Sadrzadeh SMH. Decreased prostacyclin production by liver non-parenchyrnal cells precedes liver injury in experimental alcoholic liver disease. Life Sci 1994, 54:455-461
21. Nanji AA, Zhao S, Sadrzadeh SMH, Waxman DJ: Use of reverse transcription polymerase chain reaction to evaluate in vivo cytokine gene expression in rats fed ethanol for long periods. Hepatology 1994, 19 1483-1487
22. Tahan SR, Newberg DS, Dieffenbach A, Yacoub L Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen. Cancer 1993, 71:3552-3559
23. Nanji AA, Sadrzadeh SMH, Khettry U, Thomas P, Yamanaka T: Protective effects of a novel quinone derivative (2E)-3[5-(2,3dimethoxy-6-methyl-1,4benzoquinoyl)]-2-nonyl-2-propenoic acid on experimental alcoholic liver injury. J Pharmacol Exp Ther 1993, 266: 1085-1090
24. Marugg RA, Gher P, Deleeuw M: Secondary lysosomes as an integral part of the cytoskeleton: a morphologic study in rat Kupffer cells. J Struct Biol 1990, 105.146-153
25. Massague J. The transforming growth factor-β family. Annu Rev Cell Biol 1990, 6.597-641
26. Rieder H, Armbrust T, Buschenfelde KM, Ramadori G. Contribution of sinusoidal endothelial liver cells to liver fibrosis. expression of transforming growth factor-β1 receptors and modulation of plasmin-generating enzymes by transforming growth factor-β1. Hepatology 1993, 18 937-944
27. Assoian RK, Fleurdelys BE, Stevenson HC, Miller PJ, Madtes DK, Raines EW, Ross R. Expression and secretion of type B transforming growth factor-β by activated human macrophages. Proc Natl Acad Sci USA 1987, 84 6020-6024
28. Flanders KC, Thompson NL, Cissell DS, Obberghen-Schilling E, Baker CC, Kass ME, Ellingsworth LR, Roberts AB, Sporn MB: Transforming growth factor-β1. histochemical localization with antibodies to different epitopes. J Cell Biol 1989, 108:653-659
29. Massague JS. Cheifetz S, Laiho M, Ralph DA, Weis MB, Zentell A: Transforming growth factor-β. Cancer Surv 1992, 12:81-163
30. Tsukamoto H, Horne W, Kamimura S, Niemala O, Parkilla S, Herttuala S, Brittenham GM: Experimental liver cirrhosis induced by alcohol and iron J Clin Invest 1995, 96.620-630
31. Tsukamoto H: Activation of fat-storing cells in alcoholic liver fibrosis: role of Kupffer cells and lipid peroxidation, In Sorrenti C, Casini A, Milaru S, Pinzani M eds. Falk Symposium No 71: Fat Storing Cells in Liver Fibrosis Edited by C Sorrenti, A Casini, S Milaru, M Pinzani. London, Kluwer Academic Publishers, 1994, pp 189-195
32. Kamimura S, Tsukamoto H: Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease Hepatology 1995, 22 1304-1309
33. French SW, Miyamoto K, Ohta Y, Geoffrion Y: Pathogenesis of experimental alcoholic liver disease in the rat Methods and Achievements in Experimental Pathology, vol 13. Edited by G Jasmin. Basel, S Karger, Vol 13, 1988, pp 181-207
34. Bachem MG, Meyer D, Melchior R, Sell KM, Gressner AM Activation of rat liver perisinusoidal lipocytes by transforming growth, factors derived from myofibroblast like cells: a potential mechanism of self perpetuation in liver fibrogenesis. J Clin Invest 1992, 89 19-27
35. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA. Falanga V, Kehrl JH, Fauci AS. Transforming growth factor-β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro Proc Natl Acad Sci USA 1986, 83:4167-4171
36. Reider H, Armbrust T, Buschenfelde K, Ramadori G: Contribution of sinusoidal endothelial liver cells to liver fibrosis. expression of transforming growth factor-β1 receptors and modulation of plasmin generating enzymes by transforming growth factor-β1. Hepatology 1993, 18:937-944
37. Roberts AB, Heine UI Flanders KC, Sporn MB: Transforming growth factor-β: major role in regulation of extracellular matrix Ann NY Acad Sci 1990, 580.225-232
38. Roberts AB, McCune BK, Sporn MB: TGF-β. regulation of extracellular matrix. Kidney Int 1992, 41:557-559
39. Arciniegas E, Sutton AB, Allen TD, Schor AM: Transforming growth tactor-β1 promotes differentiation of endothelial cells into smooth muscle-like cells in vitro J Cell Sci 1992, 103.521-529
40. Mak KM, Leo MA, Lieber CS Alcoholic liver injury in baboons, transformation of lipocytes to transitional cells Gastroenterology 1984, 87:188-200
41. French SW, Miyamoto K, Wong K, Juk L. Briere L: Role of the Ito cell in liver parenchymal fibrosis in rats fed alcohol and a high fat-low protein diet Am J Pathol 1988, 132:73-85
42. Tsukamoto H, Matsuoka M, French SW: Experimental models of hepatic fibrosis: a review. Semin Liver Dis 1990, 10 56-65
43. Bissell DM, Friedman SL, Maher JJ, Roll FJ: Connective tissue biology and hepatic fibrosis report of a conference Hepatology 1990, 11 488-498
44. Matsuoka M, Tsukamoto H: Stimulation of hepatic lipocyte collagen production by Kupffer cell derived transforming growth factor-β: implication for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology 1990, 11 599-605
45. Chaudry AR, D'Amore PA: Endothelial cell regulation by transforming growth factor-β J Cell Biochem 1991, 47:224-229
46. Kasinath BS: Glomerular endothelial cell proteoglycans regulation by TGF-β1 Arch Biochem Biophys 1993, 305: 370-377
47. Yamamoto T, Noble NA, Miller DE, Border WA. Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int 1994, 45:916-927
48. Takahashi H, Wong K, Jui L, Nanji AA, Mendenhall CL, French SW: Effect of dietary fat on Ito cell activation by chronic ethanol intake, a long term serial morphometric study on alcohol-fed and control rats Alcohol Clin Exp Res 1991, 15 1060-1066
49. Maher JJ, Friedman SL Parenchymal and non-parenchymal cell interactions in the liver. Semin Liver Dis 1993, 13:13-20